Bacterial cells were once treated as membrane-enclosed bags of cytoplasm: a homogeneous, undifferentiated suspension in which polymers (proteins, nucleic acids, etc.) and small molecules diffused freely to interact with each other. Biochemical studies have determined the molecular mechanisms underlying the biological processes of metabolism, replication and transcription-translation, etc. However, recent advancements in optical techniques armed with fluorescent tags for proteins and nucleic acids have increased our ability to peer into the interior of live bacterial cells. This has revealed an organized layout of multi-protein complexes, or molecular machines, dedicated to specific functions at defined sub-cellular locations; the timing of their assembly and/or rates of their activity being determined by available nutrition and environmental signals from the niche occupied by the organism. In the present study, we have attempted to identify the intracellular location and organization of the molecular machines assembled for protein synthesis (ribosomes), DNA replication (replisomes) and cell division (divisome) in different bacteria. We have used the model system Escherichia coli as well as Helicobacter pylori and mycobacterial strains (Mycobacterium marinum and Mycobacterium smegmatis), which grow at different rates and move to dormancy late into stationary phase Bacterial nucleoid plays a major role in organizing the location and movement of active ribosomes, replisomes and placement of divisome. While the active ribosomes appear to follow the dynamic folds of the bacterial nucleoid during cell growth in E. coli, inactive ribosomes appear to accumulate near the periphery. The replisome in H. pylori was visualized as a sharp, single focus upon SSB and DnaB co-localization in growing helical rods but disassembled into diffused fluorescence when the cells attained non-replicative coccoid stage. Our investigation into mycobacterial life-cycle revealed unique features such as an absence of a dedicated mid-cell site for divisome assembly and endosporulation upon entry into stationary phase. In brief, we present the cell cycle-dependent subcellular organization of molecular machines in bacteria.

Aquesta Tesi Doctoral té com objectius principals l’estudi d’Helicobacter pylori en mostres aquàtiques de Catalunya, en aigües procedents de sistemes dentals de consultes de dentistes, en saliva i en femtes de pacients amb símptomes gastrointestinals mitjançant el mètode de la PCR. També es va estudiar la supervivència d’Helicobacter pylori en aigua dolça usant un model de laboratori aplicant diferents tècniques d’anàlisi i es va interpretar el canvi de morfologia, la viabilitat i la culturabilitat de la bactèria així com la detecció i quantificació del seu ADN durant un període de temps concret. Per aconseguir aquests objectius, primer es va escollir la llet descremada al 40% v/v com a millor crioprotector i el medi agar Columbia suplementat amb 5% de sang desfibrinada de cavall com a medi de cultiu. Durant el desenvolupament de la tesi es va millorar la tècnica de PCR escollida inicialment basada amb l’estudi de Clayton i col•laboradors (1992) on s’usaven els iniciadors HPU1 i HPU2 en la PCR pel gen ureA, gen estructural de l’enzim ureasa. La tècnica de la hibridació seguida per aquests investigadors es va substituir per una segona PCR ja que aquesta permetria obtenir resultats més ràpidament. En aquesta PCR semiimbricada es va introduir un tercer iniciador intern, HPUI1, i mantenint HPU2 com a extern. Pel gen 16S rRNA, gen usat per a la detecció del gènere Helicobacter, es van usar els iniciadors 1F i 1R per a la primera PCR i els 1F i 2R per a la PCR semiimbricada. El mètode d’extracció escollit en aquest treball basat en partícules de sílice i tiocianat de guanidina descrit per Boom i col., (1990) i l’optimització de les barreges de reacció de les PCR semiimbricades pel gen ureA i 16S rRNA van permetre detectar 50 UPF/mL i 2-20UFC/mL, respectivament. Es va determinar la presència de H.pylori en mostres fecals humanes aplicant dos mètodes: mètode antigènic HpSA i l’amplificació del gen ureA. Amb el mètode molecular es va detectar la presència de ADN de H. pylori en 12 mostres i va mostrar un 75% de coincidència amb els resultats obtinguts amb el mètode antigènic HpSA. També es va determinar la presència de H. pylori a aigües amb diferent de nivell de contaminació fecal. Es va amplificar ADN d’aquesta espècie en un 30% de les mostres d’aigua residual, un 8,34% de les mostres d’aigua de riu de Catalunya i no es va detectar en aigua de font. L’estudi de supervivència de H. pylori a l’aigua en la foscor i a 7ºC es va demostrar que el recompte de bacteris i el número de genomes es manté constant durant tot el període d’estudi, 21 dies. La detecció per PCR també va ser positiva i constant durant aquest període. No obstant això, les cèl•lules només es van mantenir cultivables fins al sisè dia d’emmagatzematge. També es va observar una conversió morfològica de les cèl•lules bacterianes passant de la forma espiral a cocal amb el pas del temps. L’estudi de la morfologia cel•lular en un tall vertical d’una colònia d’H. pylori de 4 dies va mostrar la coexistència de cèl•lules amb morfologia bacil•lar i coccal. L’anàlisi de la saliva de 31 persones sanes va evidenciar la presència d’aquest bacteri en la boca de 6% de la població analitzada. La anàlisi feta amb la PCR semiimbricada per al gen 16S rRNA va identificar la presència d’aquest gen en 19 persones però la seqüenciació dels amplicons del gen ureA només va confirmar la presència de H. pylori en tres mostres. L’anàlisi de 31 mostres d’aigua procedents de les corresponents cadires no va mostra la presència del patogen. / This thesis has as main objectives the study of Helicobacter pylori in water samples from Catalonia, saliva and human feces using the PCR method. Also studied survival, morpholgy, viability and culturability of Helicobacter pylori in water. We first chose skim milk at 40% v / v as cryoprotectant and Columbia agar supplemented with 5% horse blood desfibrinada as a medium. We used a seminested PCR for ureA gene with HPU1 and HPU2 primers for the first PCR and HPUI1 and HPU2 for the second PCR. By gene 16S rRNA, we used the 1F and 1R primers for the first PCR and 1F and 2R for the second PCR. Using a silica and guanidine extraction method and optimization of the seminested PCR reaction mixtures for urea and 16S rRNA genes were detected 50 UPF / mL and 2-20UFC/mL respectively. H.pylori was detected in 12 human fecal samples. DNA of H.pylori was amplified in 30% of samples of wastewater, a 8.34% of the samples of river water in Catalonia and was not detected in spring water. The bacterial count and the number of H.pylori genomes remains constant throughout the study period, 21 days water in the dark at 7 ° C. The detection by PCR was also positive and constant during this period. The cells remained culturable only until the sixth day of storage. We observed morphological conversion of bacterial cells through the spiral to cocal over time. The study of cell morphology in a vertical section of a colony of H.pylori showed the coexistence of cells with bacillary and coccal morphology. The analysis of saliva from 31 healthy individuals showed the presence of this bacterium in the mouth of 6% of the analyzed population but we urea only confirmed the presence of H.pylori in three samples by sequencing.

Chapter 1. Deciphering the toxicity of Helicobacter pylori clinical isolates from gastric diseases patients using MALDI-TOF/MS and multivariate analysis. Helicobacter pylori (H. pyloyi) infection is associated with gastric diseases such as gastric polyp, chronic gastritis, gastric ulcer, gastric cancer, etc. In fact, most of the people infected not have the symptoms of gastric diseases due to the high degree of variability of gene with H. pyloyi and the specific immune responses of the hosts. In order to investigate the relationship between H.pylori and gastric diseases, the clinical strains of H. pylori isolated from patients from nine gastric diseases were extracted from the optimized extraction and analysis by MALDI-TOF/MS, then the high reproducible spectra were combined with multivariate statistical analysis including Principal Component Analysis (PCA), Hierarchical Cluster Analysis (HCA), Discriminant Analysis (DA) . In the result of PCA, there is no specific potential marker to discriminate the clinical strains to nine gastric diseases. In the result of HCA, the strains from different gastric diseases were clustered together means they have the similarity of the protein and metabolite. In the result of DA, the strains from gastric and non-gastric cancer were discriminanted by the discriminant function composed of thirty-eight discriminant variables in the spectra. This discriminant function would be confirmed by other clinical strains isolated from gastric diseases patients in the future and then would help to predict the the similarity of the protein and metabolite of the strains isolated from the gastric diseases patients whether gastric cancer or not. Chapter 2. Biomarker discovery in the stools of gastric cancer patients using MALDI-TOF/MS. According to the statistics of Republic 100 years from the Department of Health, cancer was the first of the ten lesding to death. With the modern change of eatiog habbits, gastrointestinal cancer has increased steadily. Gastrointestinal cancer accompanied occult gastrointestinal bleeding, and it is commonly detected by the fecal occult blood test (FOB). FOB including Guaiac-based fecal occult-blood test and immunochemical tests. Guaiac-based fecal occult-blood tests make use of the pseudoperoxidase activity of heme, and the reagent turns blue after oxidation by oxidants or peroxidases in the presence of an oxygen donor such as hydrogen peroxide, so it would have the potential of false-positive result. Immunochemical tests, which use antibodies detect against human hemoglobin with great sensitivity, but the tests are limited by loss of hemoglobin antigenicity at room temperature and require processing in a laboratory. In order to decrease the false-positive of detecting heme and decreasing the cost of the detection against hemoglobin in stools, in the study, we ues the distill water to extract the heme (m/z 616) and hemoglobin in stools and analysis with the reflectron and linear mode of MALDI-TOF/MS. In this study, at first, we used the stimulated stomach acid decomposing the hemoglobin to release the heme, to stimulate the gastrointestinal bleeding. Second, we used the distill water to extract the hemoglobin in stools, and detected by the linear mode of MALDI-TOF/MS, and the detection limit of MALDI-TOF/MS against hemoglobin in stool was better than the immunochemical tests. Third, the same strategy was applied to fifty-nine patients (including nineteen esophageal cancer patients, twenty gastric cancer patients and colorectal cancer patients) stools to detect heme and hemoglobin by MALDI-TOF/MS and the results were compared with the fecal occult blood test. In the detection of heme, MALDI-TOF/MS had not detect heme, but the Guaiac-based fecal occult-blood test had detected, it would be that the stools had the oxidants (not heme) to react the reagent. In addition, MALDI-TOF/MS had detected heme, but the Guaiac-based fecal occult-blood test had no results, those cases would be catched up in the future. In the detection of hemoglobin, using immunochemical tests to be the reference index, MALDI-TOF/MS had the false-negative result might come from the complicated matrix effect of stools, so that the hemoglobin could not form the good crystalline with matrix CHCA. The false-positive results of MALDI-TOF/MS might come from the criteria of hemoglobin signal.

El Helicobater pylori, principal agente causal de la gastritis, condiciona el estrés oxidativo debido a la producción de radicales libres. La Satureja brevicalyx, es usada para tratar problemas gastrointestinales, como la gastritis. El objetivo del presente trabajo fue caracterizar los componentes químicos, la actividad anti-Helicobacter pylori y antioxidante del aceite esencial de Satureja brevicalyx. El aceite esencial reportó un rendimiento (1.80%v/p), rotación óptica (-2 a +4º), densidad (0.9047 g/mL) e índice de refracción (1.475). Mediante CG-SM y CG-FID se elucidó 35 compuestos al 97.1%: monoterpenos oxigenados (74.8%), como componentes mayoritarios la pulegona (27.2%), linalol (20.3%), mentona (11.1%), isomentona (8.3%), cis-isopulegona (2.7%), trans-isopulegona (0.9%), carvacrol (0.6%), timol (0.6%) y α-terpineol (0.5%); hidrocarburos sesquiterpénicos (16%), destacando biciclogermacreno (8.2%), β-cariofileno (6.5%) y bicicloelemeno (0.5%); hidrocarburos monoterpénicos (4.1%), con el p-cimeno (2.0%), limoneno (0.7%) y γ-terpineno (0.6%); y sesquiterpenos oxigenados (1.5%), con el espatulenol (0.8%). Por el método de Artemia salina mostró una bioactividad significativa, con una CL50 de 13.35 μg/mL, y por el método de Dosis Fija, en ratones albinos, presenta una DL50 de 655.26 mg/kg, siendo ligeramente tóxica. Por el método de Difusión de Discos, tiene un efecto antibacteriano frente al H. pylori, con un halo de inhibición de 33.33 % en comparación con la amoxicilina a una concentración de 10 μg/mL; por el método de Difusión en Microplacas, la concentración mínima inhibitoria es de 1.00 μg/mL, y la concentración mínima bactericida de 2.00 μg/mL. Se determinó en 3 modelos la actividad antioxidante a concentraciones de 10, 50 y 100 μg/mL: 1) El aceite inhibió al radical DPPH en 67.76, 75.33 y 86.84%, frente al trolox que inhibió en 80.59, 87.17 y 93.09%; 2) secuestró al radical hidroxilo en 28.95, 51.57 y 76.84%; y 3) inhibió de la peroxidación lipídica en 16.4x10-8, 9.8x10-8 y 8.5x10-8 moles x cm, comparado con el trolox que lo hizo en 14.9x10-8, 8.0x10-8 y 7.5 x10-8 moles x cm, frente a 53.9x10-8 moles x cm para el control negativo. Las estructuras químicas del aceite esencial de la S. brevicalyx justifican su actividad anti-Helicobacter pylori y antioxidante. Palabras Clave: Satureja brevicalyx, gastritis, radicales libres, anti-Helicobacter pylori, antioxidante / The Helicobacter pylori is the main causal agent of gastritis, it conditions the oxidative stress due to the fact that it produces free radicals. The Satureja brevicalyx is used to treat gastrointestinal problems as gastritis. The objective of this work was to characterize the chemical components, the anti-Helicobacter pylori activity and the antioxidant of the main oil of Satureja brevicalyx. Te main oil reported a performance (1.80%v/p), optical rotation (- 2 to + 4º), density (0,9047 g/mL) and index of refraction (1.475). By means of CG-SM and CG-FID elucidated 35 compounds at 97,1%: oxygenated monoterpens (74,8%) as majority compound the pulegone (27,2%), linalool (20,3%), menthone (11,1%), isomenthone (8,3%), cis-isopulegone (2,7%), trans-isopulegone (0,9%), carvacrol (0,6%), thymol (0,6%) and α-terpineol (0,5%); sesquiterpenes hydrocarbons (16%), emphasizing biciclogermacrone (8,2%), β-caryophyllene (6,5%) and bicicloelemene (0,5%); monoterpenic hydrocarbons (4,1%), with the p-cymene (2,0%), limonene (0,7%) and γ-terpineno (0,6%); and sesquiterpenes (1,5%), with espatulenol (0,8%). By the method of Artemia salina it showed a significant bioactivity, with a CL50 of 13,35 μg/mL, and by the method of Fixed Dose, in albinae mice shows a DL50 of 655,26 mg/kg being slightly toxic. By the method of the Diffusion of Discs, it has an antibacterial effect of the H. pylori, with an halo of inhibition of 33,33% in comparation with the amoxiciline in a concentration of 10 μg/mL; by the method of Diffusion in Microplacas, the minimum inhibitory concentration is of 1,00 μg/mL, and the minimum bactericide concentration is of 2,00 μg/mL. The antioxidant activity to concentrations was determined in three models the concentrations must be of 10, 50 and 100 μg/mL: 1) The oil inhibited the radical DPPH in 67.76, 75,33 and 86,84%, in relation with trolox which inhibited in 80.59, 87,17 and 93,09%; 2) kidnapped the hidroxile radical in 28.95, 51,57 and 76,84%; and 3) inhibited the lipidic peroxidation in 16.4x10-8, 9.8x10-8 and 8.5x10-8 moles x cm, in relation with trolox which inhibited in 14.9x10-8, 8.0x10-8 and 7.5 x10-8 moles x cm, in relation to a 53.9x10-8 moles x cm for the negative control. The chemical structures of the main oil of the S. brevicalyx justify its activity as an anti-Helicobacter pylori and as an antioxidant. Key Words: Satureja brevicalyx, gastritis, free radicals, anti-Helicobacter pylori, antioxidant

<p>The development of improved sequencing technologies hasenabled the field of genomics to evolve. Handling andsequencing of large numbers of samples require an increasedlevel of automation in order to obtain high throughput andconsistent quality. Improved performance has lead to thesequencing of numerous microbial genomes and a few genomes fromhigher eukaryotes and the benefits of comparing sequences bothwithin and between species are now becoming apparent. Thisthesis describes both the development of automated purificationmethods for DNA, mainly sequencing products, and a comparativesequencing project.</p><p>The initially developed purification technique is dedicatedto single stranded DNA containing vector specific sequences,exemplified by sequencing products. Specific capture probescoupled to paramagnetic beads together with stabilizing modularprobes hybridize to the single stranded target. After washing,the purified DNA can be released using water. When sequencingproducts are purified they can be directly loaded onto acapillary sequencer after elution. Since this approach isspecific it can be applied to multiplex sequencing products.Different probe sets are used for each sequencing product andthe purifications are performed iteratively.</p><p>The second purification approach, which can be applied to anumber of different targets, involves biotinylated PCR productsor sequencing products that are captured using streptavidinbeads. This has been described previously, buthere theinteraction between streptavidin and biotin can be disruptedwithout denaturing the streptavidin, enabling the re-use of thebeads. The relatively mild elution conditions also enable therelease of sensitive biotinylated molecules.</p><p>Another project described in this thesis is the comparativesequencing of the 40 kb<i>cag</i>pathogenicity island (PAI) in four<i>Helicobacter pylori</i>strains. The results included thediscovery of a novel gene, present in approximately half of theSwedish strains tested. In addition, one of the strainscontained a major rearrangement dividing the<i>cag</i>PAI into two parts. Further, information about thevariability of different genes could be obtained.</p><p><b>Keywords:</b>DNA sequencing, DNA purification, automation,solid-phase, streptavidin, biotin, modular probes,<i>Helicobacter pylori</i>,<i>cag</i>PAI.</p>

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2009. / Härtill 4 uppsatser.

Zugl.: Berlin, Humboldt-Univ., Diss., 2009

published_or_final_version / Medicine / Doctoral / Doctor of Philosophy

Most gram-negative organisms require lipopolysaccharide and its membrane anchor, lipid A, for growth and survival. Also known as endotoxin, lipid A is synthesized via a nine-step enzymatic process, culminating in a conserved hexa-acylated, bis-phosphorylated disaccharide of glucosamine. This framework is often altered by condition- or species-specific lipid A modifications, which change the biochemical properties of the molecule in response to and to defend against environmental stress signals. Here, we expound on two stories in different gram-negative organisms, both involving novel or unanticipated biochemistry that impacts lipid A structure. First, the missing acyltransferase in the Epsilonproteobacterium Helicobacter pylori lipid A biosynthesis pathway is identified. This enzyme transfers a secondary acyl chain to the 3'-linked primary acyl chain of lipid A like E. coli LpxM, but shares almost no sequence similarity with the E. coli acyltransferase. It is reannotated as LpxJ and demonstrated to possess an unprecedented ability to act before the 2'-secondary acyltransferase, LpxL, as well as the 3-deoxy-D-manno-octulosonic acid transferase, KdtA. LpxJ is one member of a large class of acyltransferases found in a diverse range of organisms that lack an E. coli LpxM homolog, suggesting that LpxJ participates in lipid A biosynthesis in place of an LpxM homolog. The second story focuses on regulation of modifications to endotoxin structure that occur after the conserved biosynthesis pathway. E. coli pmrD is shown to be required for PmrAB-dependent lipid A modifications in conditions that exclusively activate PhoPQ; this result proves that PmrD connects PhoPQ and PmrAB despite previous reports that it is an inactive connector in this organism. Further, RNA sequencing and polymyxin B survival assays solidify the role of E. coli pmrD in influencing expression of pmrA and its target genes and promoting survival during exposure to cationic antimicrobial peptides. Notably, the presence of an unknown factor or system capable of activating pmrD to promote lipid A modification in the absence of the PhoPQ system is also revealed. In all, the findings presented here expand our understanding of alternative approaches to lipid A biosynthesis and the complex systems that regulate modifications of this dynamic molecule.

Adenovirus serotype 5 (Ad5) is widely used as an oncolytic agent for cancer therapy. However, its infectivity is highly dependent on the expression level of coxsackievirus-adenovirus receptor (CAR) on the surface of tumor cells. We engineered Ad5 virus with the protein transduction domain (PTD) from the HIV-1 Tat protein (Tat-PTD) inserted in the hypervariable region 5 (HVR5) of the hexon protein in the virus capsid. Tat-PTD-modified Ad5 shows a dramatically increased transduction level of CAR-negative cells and bypassed fiber-mediated transduction. It also overcomes the fiber-masking problem, which is caused by release of excess fiber proteins from infected cells. To achieve specific viral replication in neuroblastoma and neuroendocrine tumor cells, we identified the secretogranin III (SCG3) promoter and constructed an adenovirus Ad5PTD(ASH1-SCG3-E1A) wherein E1A gene expression is controlled by the SCG3 promoter and the achaete-scute complex homolog 1 (ASH1) enhancer. This virus shows selective and efficient killing of neuroblastoma cell lines in vitro, and delays human neuroblastoma xenograft tumor growth on nude mice. To further enhance the viral oncolytic efficacy, we also switched the fiber 5 to fiber 35 to generate Ad5PTDf35. This vector shows dramatically increased transduction capacity of primary human cell cultures including hematopoietic cells and their derivatives, pancreatic islets and exocrine cells, mesenchymal stem cells and primary tumor cells including primary cancer initiating cells. Ad5PTDf35-based adenovirus could be a useful platform for gene delivery and oncolytic virus development. Viral oncolysis alone cannot completely eradicate tumors. Therefore, we further armed the Ad5PTDf35-D24 virus with a secreted form of Helicobacter pylori Neutrophil Activating Protein (HP-NAP). Expression of HP-NAP recruits neutrophils to the site of infection, activates an innate immune response against tumor cells and provokes a Th1-type adaptive immune response. Established tumor on nude mice could be completely eradicated in some cases after treatment with this virus and the survival of mice was significantly prolonged.